Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin-associated protein 12-2 (KRTAP12-2) is a high-sulfur matrix protein found in the hair cortex, where it interacts with keratin intermediate filaments. It is part of the family of keratin-associated proteins (KAPs), which collectively cross-link with hair keratins via disulfide bonds, contributing to the mechanical strength and resistance of hair fibers. KRTAP12-2 serves primarily a structural role in the formation and stability of hair. It is encoded by the KRTAP12-2 gene and is highly expressed in hair-forming tissues. KRTAPs are subdivided by amino acid content, and KRTAP12-2 belongs to the high-sulfur KAP group. The protein is neither a receptor, enzyme, transporter, nor transcription factor. There are no documented drugs or small molecules known to interact specifically with KRTAP12-2, nor is there evidence describing it as a clinical biomarker or therapeutic target. Weak disease associations (e.g., Choroid Plexus Cancer, Three M Syndrome 1) appear to be based on gene locus proximity or genome-wide studies, not direct mechanistic involvement, and it is not recognized as a therapeutic target or biomarker in current clinical or biomedical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin-associated protein 12-2 (KRTAP12-2).